Martin Johansson
Chief Executive Officer at Glactone Pharma AB
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Olov Arvid Sterner | M | 71 |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden.
University of Lund
| - |
Anders Sigvard Bjartell | M | 65 |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden.
University of Lund
| 12 years |
Rebecka Hellsten | F | - |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | 12 years |
Nils Olof Jarlman | M | 70 |
University of Lund
| - |
Petter Pilesjö | M | - |
University of Lund
| - |
Inge Pettersson | M | 77 |
University of Lund
| 16 years |
Jacob Engellau | M | 61 |
University of Lund
| - |
Ebba Cecilia Fåhraeus | F | 61 |
University of Lund
| 9 years |
Jeanette Robertsson | M | - |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | 11 years |
Rajni Hatti-Kaul | M | 65 |
University of Lund
| 20 years |
Petr Dejmek | M | 79 |
University of Lund
| 35 years |
Mef Nilbert | F | 57 |
University of Lund
| - |
Torleif Dahlin | M | 67 |
University of Lund
| - |
Ingegerd Monica Sjöholm | F | 75 |
University of Lund
| - |
Stig Steen | M | 76 |
University of Lund
| - |
Annika Maria Olsson | M | 62 |
University of Lund
| - |
Stefan Hansson | M | 59 |
University of Lund
| - |
Peter Leander | M | 67 |
University of Lund
| - |
Malin Marie Lindstedt | F | 49 |
University of Lund
| - |
Anna Kerstin Emy Hultgårdh Nilsson | M | 66 |
University of Lund
| - |
Per Norlén | M | 54 |
University of Lund
| - |
Andreas Konar | M | 75 |
University of Lund
| - |
Merab Kokaia | M | 68 |
University of Lund
| - |
Ronald W. Pero | M | - |
University of Lund
| - |
Leif-Göran Salford | M | 83 |
University of Lund
| - |
Lena Mårtensson | M | 70 |
University of Lund
| - |
Susanne Kristensson | F | - |
University of Lund
| - |
Anders Nilsson | M | 56 |
University of Lund
| - |
Mauricio Rojas Mullor | M | - |
University of Lund
| - |
Gabriela Godaly | F | - |
University of Lund
| - |
Malin Malmsjö | M | 51 |
University of Lund
| - |
Jonas Hafström | M | - |
University of Lund
| - |
Björn Kettilsson Wullt | M | 68 |
University of Lund
| - |
Viktor Öwall | M | 69 |
University of Lund
| - |
Magnus Fontes | M | 61 |
University of Lund
| - |
Carl-Henric Lennart Nilsson | M | 64 |
University of Lund
| - |
Bill Hansson | M | - |
University of Lund
| - |
Christer Thordson | M | 66 |
University of Lund
| - |
Karin Leandersson | F | 52 |
University of Lund
| - |
Jan Birger Fredrik Toernell | M | 64 |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | 12 years |
Roland Andersson | M | 69 |
University of Lund
| 24 years |
Catharina Svanborg | M | 75 |
University of Lund
| 35 years |
Sofia Ulver | M | 53 |
University of Lund
| - |
Kristina Drott | M | 53 |
University of Lund
| - |
Lars Christer Oxelheim | M | 80 |
University of Lund
| - |
Jan Nilsson | M | 71 |
University of Lund
| - |
Helena Norrman | F | 54 |
University of Lund
| - |
Bengt Arvid Westrin | M | 66 |
University of Lund
| 25 years |
Tadeusz Wojciech Wieloch | M | 74 |
University of Lund
| - |
Magnus Ingelsten | M | - |
University of Lund
| - |
Jan-Erik Solem | M | - |
University of Lund
| - |
Artur Schmidtchen | M | - |
University of Lund
| - |
Jörgen Hegbrant | M | 67 |
University of Lund
| - |
Stina Margareta Gestrelius | M | 75 |
University of Lund
| - |
Fredrik Höök | M | - |
University of Lund
| 20 years |
Margareta Linden | M | - |
University of Lund
| 31 years |
Sven Fredrik Tiberg | M | 61 |
University of Lund
| - |
Henrik Tobias Thorlacius | M | 55 |
University of Lund
| - |
Jan Erik Ragnar Söderberg | M | 68 |
University of Lund
| - |
Boel Flodgren | M | 82 |
University of Lund
| - |
Tomas Leanderson | M | 68 |
University of Lund
| 34 years |
Ingrid Anne-Marie Pålsson | M | 73 |
University of Lund
| - |
Jan Thorell | M | - |
University of Lund
| - |
Klas Rune Arildsson | M | 64 |
University of Lund
| - |
Lars Gösta Montelius | M | 66 |
University of Lund
| - |
Ulla Cristina Glad | M | 72 |
University of Lund
| - |
Lars-Erik Magnus Wernersson | M | 56 |
University of Lund
| 19 years |
Peter Spégel | M | 47 |
University of Lund
| - |
C. Mike Lu | M | 54 |
University of Lund
| - |
Guido Zacchi | M | 74 |
University of Lund
| 35 years |
Signhild Lou E Arnegård-Hansen | F | 64 |
University of Lund
| - |
Jonas Erjefält | M | 58 |
University of Lund
| - |
Boris Zhmud | M | - |
University of Lund
| - |
Jeanette Jakobsson | F | 57 |
University of Lund
| - |
Per Belfrage | M | 84 |
University of Lund
| - |
Inga Sarah Maria Fredriksson | M | 56 |
University of Lund
| - |
Peter Jelkeby | M | 61 |
University of Lund
| - |
Thoas Michael Fioretos | M | 66 |
University of Lund
| - |
Tommy Evert Andersson | M | 68 |
University of Lund
| 28 years |
Lars Magnus Thomas Bjursten | M | 75 |
University of Lund
| 35 years |
Hakon Leffler | M | - |
University of Lund
| - |
Carl Johan Kördel | M | 62 |
University of Lund
| 30 years |
Jacob Nejtel Kaluski | M | 73 |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | 10 years |
Mona Annelie Sylvén-Troedsson | F | 75 |
University of Lund
| - |
Sune Roland Svanberg | M | 81 |
University of Lund
| - |
Gustaf Olsson | M | 84 |
University of Lund
| 18 years |
Bo Mattiasson | M | - |
University of Lund
| 52 years |
Jing Liu | M | 53 |
University of Lund
| - |
Javier Linares-Pastén | M | 60 |
University of Lund
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gustav Ingemar Kihlström | M | 71 |
Respiratorius AB
Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | - |
Eduardo Munoz | M | - |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 91 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Johansson
- Personal Network